India to Thailand: Erlotinib Export Trade Route

The India to Thailand Erlotinib corridor is one of India's established pharmaceutical export routes, with 17 shipments documented worth a combined $506.0K USD. The route is dominated by NATCO PHARMA LIMITED , which alone accounts for roughly 69% of all export value, reflecting the consolidated nature of India's erlotinib manufacturing sector.

Across 8 active suppliers, the average shipment value stands at $29.8K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 80% of all shipments, consistent with erlotinib's non-urgent bulk-order profile.

Shipment activity peaks during July–September, with an average transit time of 26 days port-to-port. The route has recorded an annual growth rate of 22.3%, placing it at rank #3 among India's top erlotinib export destinations globally.

On the import side, key buyers of Indian erlotinib in Thailand include ATLANTA MEDICARE CO.LTD , ATLANTA MEDICARE CO. LTD , ATLANTA MEDICARE CO.LIMITED and 6 others. ATLANTA MEDICARE CO.LTD is the single largest importer with 2 shipments valued at $235.7K USD.

India's erlotinib exports to Thailand are driven primarily by a handful of large-scale manufacturers. NATCO PHARMA LIMITED with 3 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 8 active exporters signals a competitive but concentrated market — buyers in Thailand benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — NATCO PHARMA LIMITED , NATCO PHARMA LIMITED, KARDI TRADING PRIVATE LIMITED — together account for 97% of total trade value on this route. The average shipment value of $29.8K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as erlonat/erlotinib 150mg tablets (7680x30 and erlonat/erlotinib 150mg tablets 30's(7031x30's)(appendix 4r,rodtep entry no:10112)(other ref(s)ci no:123263)nos, suggesting that buyers in Thailand tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, ATLANTA MEDICARE CO.LTD is the largest importer with 2 shipments worth $235.7K USD — representing 47% of all erlotinib imports from India on this route. A total of 9 buyers are active on this corridor.